A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.
Conditions
Tuberculosis (TB)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Victoria Biomedical Research Institute, Kisumu, Kenya
Kenya Medical Research Institute, Nairobi, Kenya
JOSHA Research, Bloemfontein, South Africa
South African Tuberculosis Vaccine Initiative, Cape Town, South Africa
TASK Applied Science Pty Ltd. TASK Delft, Cape Town, South Africa
UCTLI CLII - Centre for Lung Infection and Immunity, Cape Town, South Africa
University of Cape Town Lung Institute PtyLtd. Centre for Tuberculosis Research Innovation, Cape Town, South Africa
Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South Africa
Synergy Biomedical Research Institute, East London, South Africa
TASK Eden Pty Ltd., George, South Africa
Perinatal HIV Research Unit, Johannesburg, South Africa
Be Part Research Pty Ltd., Paarl, South Africa
The Aurum Institute Rustenburg Clinical Research Centre, Rustenburg, South Africa
Desmond Tutu Health Foundation, Masiphumelele Research Office, Sunnydale, South Africa
The Aurum Institute Tembisa Clinical Research Centre, Tembisa, South Africa
Ifakara Health Institute, Dar es Salaam, Tanzania